3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
116
Thoracic
21
Genitourinary
19
Gynecologic
15
Dermatologic
11
Sarcoma
9
Head & Neck
9
CNS
9
Breast
8
Endocrine
4
Plasma cell
3
NET
2
Lymphoid
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Neuroendocrine Tumors
34
Pheochromocytoma
4
Paraganglioma
4
Carcinoma, Neuroendocrine
4
Sarcoma
3
Pancreatic Neoplasms
3
Neoplasms
3
Meningioma
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Carcinoid Tumor
3
Adenoma, Islet Cell
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Neoplasm Metastasis
2
Melanoma
2
Medulloblastoma
2
Liver Neoplasms
2
Insulinoma
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Gastro-enteropancreatic neuroendocrine tumor
2
Digestive System Neoplasms
2
Colonic Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
NET
×
30 days
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled
NCT06735560
2026-05-13
ELEGANCE
Nantes University Hospital
Phase NA
Recruiting
60 enrolled